Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00711568 · ClinicalTrials.gov registry record · Phase 2
A Clinical Trial of Magnetic Stimulation in Depression
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
NCT00711568 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 48 participants.
The verdict
NCT00711568, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether repetitive high field transcranial magnetic stimulation of the left or right frontal lobes is beneficial for the treatment of depression that is refractory to antidepressant medication.
Interventions
- PROCEDURE Repetitive transcranial magnetic stimulation (rTMS)
- PROCEDURE Sham rTMS
- DEVICE Repetitive Transcranial Magnetic Stimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2001-10 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00711568
The ClinicalTrials.gov registry entry for NCT00711568 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Repetitive transcranial magnetic stimulation (rTMS) is the first listed.
NCT00711568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00711568 about?
NCT00711568 is a clinical study titled "A Clinical Trial of Magnetic Stimulation in Depression". The purpose of this study is to determine whether repetitive high field transcranial magnetic stimulation of the left or right frontal lobes is beneficial for the treatment of depression that is refractory to antidepressant medication.
What is the current status of trial NCT00711568?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2001-10. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00711568?
The interventions under investigation include: Repetitive transcranial magnetic stimulation (rTMS) (PROCEDURE), Sham rTMS (PROCEDURE), Repetitive Transcranial Magnetic Stimulator (DEVICE).
Who is sponsoring clinical trial NCT00711568?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.